ArticlePharmaceuticals (Basel, Switzerland)2026
PCSK9 Inhibitor Use and the Risk of Age-Related Macular Degeneration in Patients with Atherosclerotic Cardiovascular Disease.
Hou-Ren Tsai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.